Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Labs' Innovation and Leadership Will Light Up Chicago

By Karen Blum (AACC)
Posted on 12 Jul 2022
When the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo kicks off this summer, it will mark the culmination of nearly 2 years of work by members of the Annual Meeting Organizing Committee (AMOC), who have been busy planning since October 2020. More...


“It's a long, intense process,” said Linnea Baudhuin, PhD, AMOC chair and professor of laboratory medicine and pathology at Mayo Clinic. “We get hundreds of session proposals and abstracts, and we go through each one carefully to ensure we’re providing well-rounded, high-quality content.”

Here, Baudhuin provides a preview of the 5-day meeting, to be held July 24-28 in Chicago.

Q: WHAT ARE YOU MOST LOOKING FORWARD TO AT THIS YEAR'S MEETING?
A: The meeting is always an inspiring, engaging event. It’s a great forum for attendees to learn from global leaders in laboratory medicine and network with colleagues. We’ll have over 250 educational opportunities in formats from lectures to interactive sessions, and roundtables to plenaries. We have an incredibly diverse group of speakers from around the world, covering all aspects of laboratory medicine and cutting-edge science.

The expo will showcase the latest technologies, including over 200 new products. We’ll have the popular Disruptive Technology competition, the Student Research and Oral Abstract awards, and the always hilarious Laboratory Feud. The meeting has so much to offer to everyone.

I'm also excited about the location. Chicago is such a fun city to visit, with great museums, a beautiful lakefront and riverfront, and amazing architecture. There’s always so much to do, especially in the summer.

HOW HAVE CHANGES IN LABORATORY MEDICINE AFFECTED THE MEETING CONTENT?
During COVID-19, laboratory medicine was a beacon of light that revealed to the world how critical our field is to healthcare. Now is the time to continue that wave of success and continue to shine through innovation and leadership.

We also need to be aware that spotlights placed on our field have led to increased interest in some legislature initiatives, including the VALID Act, which would expand the Food and Drug Administration’s power to regulate laboratory-developed tests (LDTs). It’s critically important that we understand the implications of these initiatives on our field. The “Valid Vital LDTs” expert session on Monday, July 25, is a great way to learn more about these important issues.

It's also become apparent that laboratory medicine professionals are passionate about providing optimal health care for diverse populations. We are excited this year to offer six pathways of sessions, including one on transforming population health and equity, as well as mobilizing data analytics, accelerating molecular diagnostics, and elevating point-of-care testing.

WHAT ABOUT CURRENT MEDICINE AND SCIENCE MAKES IT CRITICAL FOR US TO COLLABORATE IN THIS MANNER?
We’re living in an era of data and information. The vast amounts of data we can generate today present opportunities to make new discoveries and advance healthcare through data sharing. Connecting at the meeting can open opportunities to share data and form collaborations to make new discoveries. In that vein, several of our sessions are geared toward optimizing discoveries through data analytics and informatics.

We are also living in an era of connectivity through social media platforms. Social media can be a great tool to enhance your professional presence, connect, and discover new things about the field. I'm looking forward to our “Social Media in Laboratory Medicine” session.

With all the information thrown at us today, the meeting provides a terrific opportunity to take time to focus on our field. By enhancing our knowledge and creating connections, we can continue to elevate laboratory medicine and its importance in patient care.

WAS CAN ATTENDEES EXPECT TO TAKE AWAY FROM THIS MEETING?
I thank the 2022 AMOC for their incredible vision and hard work. We have a gamut of clinical and scientific sessions covering areas like cardiology, endocrinology, immunology, infectious disease, oncology, personalized medicine, and others. The meeting is an excellent opportunity to learn about the latest in mass spectrometry, machine learning and data analytics, translational medicine, and lab management. I encourage everyone to take advantage of all that the meeting has to offer. If you see me walking around the convention center, please say hello, and let me know what you are enjoying most about the meeting.






Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
An overview of the study and findings: A) Several brain-derived EVPs cross the blood brain barrier and reach circulation. B) Different EVPs enrich different RNA cargo B) The EVP-RNA is impacted, upregulated (green) or downregulated (red) in AD (Gonzalez-Kozlova, E., et al., Nature Communications (2026). doi.org/10.1038/s41467-026-74541-8)

RNA Blood Test May Enable Earlier Alzheimer’s Disease Diagnosis

Alzheimer’s disease affects an estimated 55 million people worldwide and remains difficult to diagnose at an early stage. Diagnostic workups can be complicated by symptom overlap with other conditions,... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.